Envista
QUAKERTOWN, PA / ACCESSWIRE / May 16, 2024 / Today, DEXIS launches the latest innovation in its digital ecosystem with an all-new dental intraoral sensor, the DEXIS™ Ti2 Sensor. The DEXIS digital ecosystem is a comprehensive, AI-powered platform for dental imaging, designed to connect and streamline digital workflows for enhanced productivity.
To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.DEXIS Ti2 Sensor
The Ti2 sensor builds on the success of its predecessor, the DEXIS™ Titanium Sensor, the #1 digital intraoral sensor in the United States.* In 2023, DEXIS sensors processed over 167 million images, making it a top choice for intraoral sensors and scanners, as well as x-ray and CBCT technology worldwide.
Bringing several new features to the DEXIS 2D imaging portfolio, the Ti2 sensor includes:
- A housing design that's twice as durable as previous generations
- A proactive servicing module
- Access to 2D AI Dental Findings that automatically detect up to six types of dental findings on 2D radiographs
With DEXIS, 2D AI Dental Findings are integrated into both DTX Studio™ Clinic and DEXIS Imaging Suite software-not a separate third-party application. 2D AI Dental Findings automatically identifies periapical radiolucency, bone loss, calculus, caries, discrepancy at margin of existing restoration, and root canal filling deficiency.
"For patients with periodontal disease, we have identified sub-gingival calculus and monitored their bone levels. Caries detection and diagnosis is clear and precise with the contrast available with these images," said Dr. Moe Katz of Katz & Pfeffer Dental Studio.
The Ti2 sensor housing is twice as durable and two times as drop-resistant as the Titanium Sensor. The new posterior holder and WiseAngle™ cable design reduce stress on the sensor/cable connection, further strengthening the Ti2 sensor.
DEXIS also focuses on maximizing the productivity of the dental practice with the newly launched DEXIS Connect Pro. The solution proactively monitors the health of the DEXIS family of sensors through IoT technology and automatically arranges support or equipment replacements if performance issues are ever detected.
"DEXIS Connect Pro provides the kind of customer experience I've come to expect from DEXIS," says Amber Metro-Sanchez, dental hygienist at Omni Dental. "The knowledge that my sensor communicates with DEXIS support and that they're ready to help me if I ever need it gives me peace of mind. They've always been so responsive and helpful, DEXIS Connect Pro demonstrates the kind of attention to customer care and continuous innovation I've grown accustomed to with DEXIS."
Through the use of CleanCapture™ technology, the Ti2 sensor captures high-resolution images by reducing noise and enhancing anatomical detail. The technology allows the sensor to be flexible and ready to adapt to varying exposure levels, generator usage, or positioning techniques to capture clear, accurate images reliably - even in challenging circumstances.
Equipped with its PerfectSize™ design, the Ti2 sensor is engineered to fit every patient comfortably, making it a convenient, one-size-fits-all solution for busy practices.
Experience the new DEXIS Ti2 Sensor at booth 1665 at CDA South on May 16-18, 2024.
*DEXIS Titanium Sensor- December 2023 SDM US Market Share Data.
About DEXIS
DEXIS has been a global leading brand in digital radiography for 70+ years. Today, DEXIS has brought together the most trusted brands in 3D imaging, intraoral scanning solutions, and diagnostic software to provide patients with a complete digital diagnostic solution under a brand name. Our innovative award-winning technology enhances how the patient is diagnosed, accelerates the workflow, and delivers simple treatment paths with better patient outcomes. For more information, please visit https://www.dexis.com.
Contact Information:
Hayley Reed
Regional Marketing Director, DEXIS IOS
hayley.reed@envistaco.com
(714) 628-8533
SOURCE: DEXIS
To view this piece of content from stats.nwe.io, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma17.11.2025 13:00:00 CET | Press release
OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer. TAIPEI, TW / ACCESS Newswire / November 17, 2025 / OBI Pharma, a clinical-stage oncology company (4174.TWO) received notification from the US FDA stating that the request for Orphan Drug Designation of OBI-902 TROP2 ADC for the treatment of Cholangiocarcinoma has been granted. OBI-902 is the first OBI-developed ADC that incorporates our proprietary site-specific glycan-conjugated ADC enabling technology. Cholangiocarcinoma is a rare and lethal malignancy with fewer than 50,000 patients in the United States and a 5-year survival rate ranging from 2% and 23% depending on disease stage, histological subtype, and localization 1 . At present, there are no FDA approved ADC therapies for cholangiocarcinoma. To encourage the industry to develop new treatment options for rare diseases, the US FDA grants Orphan Drug Designation to exper
Camino Completes C$5.6 Million Investment with Strategic Investors17.11.2025 12:00:00 CET | Press release
VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC:CAMZF) ("Camino" or the "Company") is pleased to announce the closing of its -brokered private placement (the "Financing") of common shares in the capital of the Company (the "Shares") previously announced in its news release dated November 12, 2025. Under the Financing, the Company issued an aggregate of 15,554,666 Shares at an issue price of $0.36 per Share, for aggregate gross proceeds of C$5,599,680. Participants in the Financing included two new key shareholders, Elemental Royalties (formerly EMX Royalty Corp.) and Continental General Insurance Company, as well as certain insiders of Camino. The gross proceeds of the Financing will be applied towards corporate working capital, legal expenses, engineering studies, project development, and general administrative expenses. The Shares issued pursuant to the Financing are subject to a statutory hold period expiring on March 15, 2026, in acc
GA-ASI Completes Full-Scale Fatigue Test on MQ-9B17.11.2025 03:10:00 CET | Press release
MQ-9B's Third Lifetime Test Completes the FSF Testing Process With a Total of 120,000 Hours DUBAI, UAE / ACCESS Newswire / November 16, 2025 / On October 31, 2025, General Atomics Aeronautical Systems, Inc. (GA-ASI) completed its "third lifetime" of full-scale fatigue (FSF) testing for the MQ-9B Remotely Piloted Aircraft (RPA). Completion of FSF testing for the third and final lifetime includes a total of 120,000 operating hours (40,000+ flight hours per aircraft life) for the RPA and is a key milestone in validating the design of the airframe. The testing verifies the airframe structural integrity in support of certification to the NATO STANAG 4671 standard. The aim of the testing is to identify any potential structural deficiencies ahead of fleet usage and assist in developing inspection and maintenance schedules for the airframe. Test results will be used as documentation for certification and will form the basis for in-service inspections of structural components. "The completion o
GA-ASI and Saab Will Demonstrate AEW&C on MQ-9B in 202617.11.2025 03:05:00 CET | Press release
Two Aerospace Leaders Are Bringing Airborne Early Warning and Control to UAS DUBAI, UAE / ACCESS Newswire / November 16, 2025 / Following their announcement to bring Airborne Early Warning and Control (AEW&C) capability to the world's leading Remotely Piloted Aircraft (RPA) platform, General Atomics Aeronautical Systems, Inc. (GA-ASI) and Saab will now team up to demonstrate the capability in the summer of 2026. The demo will be conducted at GA-ASI's Desert Horizon flight operations facility in Southern California using a GA-ASI MQ-9B equipped with AEW&C supplied by Saab. In partnership with Saab, a leading company in AEW&C systems, GA-ASI is pairing Saab's AEW sensors with the world's longest-range, highest-endurance RPA, the MQ-9B. At sea or over land, adding AEW capabilities on MQ-9B enables persistent air surveillance and enables AEW in areas of the world where it doesn't currently exist or is unaffordable, such as for navy aircraft carriers at sea. "Adding AEW&C to the MQ-9B bring
Doha Tattoo Festival Announced as Ticket Sales Officially Open16.11.2025 12:45:00 CET | Press release
DOHA, QA / ACCESS Newswire / November 16, 2025 / Under the patronage of His Excellency Sheikh Khalifa bin Hamad bin Khalifa Al Thani, Minister of Interior and Commander of the Internal Security Force (Lekhwiya), the first edition of the Doha International Music and Marching Festival (Doha Tattoo) will be held from 16 to 20 December 2025 at Katara Cultural Village. A press conference held at Katara Cultural Village unveiled the line-up of participating bands and ticket details, attended by members of the Doha Tattoo organising committee and partner representatives. The Doha Tattoo will combine precision with musical artistry, showcasing performances by distinguished musical bands from seven countries: the United Kingdom, the United States of America, Turkia, Hashemite Kingdom of Jordan , the Sultanate of Oman, Kazakhstan, and the State of Qatar. The participating line-up includes the Irish Guards and the Royal Air Force Music Services from the United Kingdom, the United States Air Force
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom